HCG inches to the finish line on Indian IPO
Indian cancer care company HealthCare Global Enterprises had seen a slow response to its Rp6.5bn ($97.5m) IPO heading towards the end of bookbuilding on Friday with only 84% of the deal subscribed.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: